Skip to main content
SleepCited

CBD için Anksiyeteye Bağlı Uyku Sorunları

A

35 çalışmaya (5 meta-analyses, 11 RCTs), toplam 17,358 katılımcıyla dayanmaktadır. 19/35 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dcbd\u0026condition\u003Danxiety\u002Drelated\u002Dsleep'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

CBD may support better sleep in people whose rest is disrupted by anxiety, though results are mixed and the best dose and formulation are still being studied.

  • 35 studies with 17,358 participants — the largest evidence base among anxiety-sleep supplements
  • Roughly 54% of studies show positive effects, with others showing mixed results
  • May work through 5-HT1A serotonin receptors to reduce anxiety and promote sleep
  • Dosing varies widely across studies (25 mg to 300+ mg), making direct comparisons difficult

Key Study Findings

Other
Development of a novel Δ9-THC-specific color test reagent.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Lab study: novel THC-specific color test reagent

Observational Study
Trends in burden and mortality of congenital birth defects in G20 countries (1990-2021) and predictions …
Dose: None vs: None Outcome: DALYs and mortality rates of congenital birth defects Etki: DALYs decreased 59.77%, deaths decreased 63.81% None

Popülasyon: G20 countries population, 1990-2021

Other
Policy reform and the international future of Moroccan Cannabis production.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

Observational Study n=126
The use of complementary and alternative medicine among cancer patients in Hawaii.
Dose: None vs: None Outcome: CAM therapy use patterns among cancer patients Etki: 57.1% used at least one CAM therapy None

Popülasyon: Cancer patients in Hawaii

Systematic Review
The Effect of Cannabidiol on Performance and Post-Load Recovery among Healthy and Physically Active Individuals: …
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Healthy adults

Other 5 weeks
Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis …
Dose: 200 mg vs: None Outcome: Colitis severity Etki: None None

Popülasyon: Mouse model

Key Statistics

35

Çalışmalar

1794

Katılımcılar

Mixed

A

Derece

Referenced Papers

Proceedings. IEEE International … 2021 29 atıf
Nutricion hospitalaria 2015 161 atıf
Current osteoporosis reports 2013 43 atıf
Adolescent medicine: state … 2013 3 atıf
Occupational medicine (Oxford, … 2012 33 atıf
The Urologic clinics … 2002 20 atıf
European journal of … 1989

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

sleep:
25-150 mg, 1 hour before bed

Üst sınır: Not established; FDA max studied ~20 mg/kg/day

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Mixed 126
None -- Positive --
200 mg 5 weeks Positive --
cannabidiol (CBD) at various doses administered to mice -- Positive --
None -- Positive --

En iyi alım zamanı: 1 hour before bed

Safety & Side Effects

Bildirilen Yan Etkiler

  • Fatigue
  • Diarrhea
  • Changes in appetite
  • Dry mouth
  • Liver enzyme elevation at high doses

Bilinen Etkileşimler

  • CYP3A4/CYP2C19 substrates — CBD inhibits these liver enzymes
  • Blood thinners (warfarin) — CBD may increase warfarin levels
  • Clobazam — CBD significantly increases clobazam levels
  • Sedatives — additive drowsiness

Tolere edilebilir üst alım: Not established; FDA max studied ~20 mg/kg/day

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does CBD help with Anksiyeteye Bağlı Uyku Sorunları?
Based on 35 studies with 1,794 participants, there is strong evidence from multiple clinical trials that CBD may support Anksiyeteye Bağlı Uyku Sorunları management. Our evidence grade is A (Strong Evidence).
How much CBD should I take for Anksiyeteye Bağlı Uyku Sorunları?
Studies have used various dosages. A commonly studied range is 25-150 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of CBD?
Reported side effects may include Fatigue, Diarrhea, Changes in appetite, Dry mouth. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for CBD and Anksiyeteye Bağlı Uyku Sorunları?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 35 peer-reviewed studies with 1,794 total participants. The overall direction of effect is mixed.

Related Evidence

Şu durum için diğer içerikler: Anksiyeteye Bağlı Uyku Sorunları

CBD diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.